Anti-Viral Therapy

Press Release | Marin Biologic Labs Achieves Flawless FDA Inspection for Second Consecutive Year, Expands Biopharmaceutical Services What are PROTACs? Proteolysis Targeting Chimeric (PROTAC) drugs are innovative molecules that utilize the ubiquitin-proteasome system to selectively degrade specific proteins within cells. PROTACs are one of the most promising methods for targeted protein degradation (TDP), which is […]

Depiction of PROTAC recruiting an E3 ubiquitin ligase to a protein of interest

Recent Articles​

Inhaler-Based Immunotherapy for Lung Cancer
Anti-Viral Therapy

Inhaler-Based Immunotherapy for Lung Cancer

Lung cancer is among the most lethal malignancies worldwide, with limited therapeutic success despite advancements in immunotherapy. Immune checkpoint inhibitors (ICIs), particularly those targeting PD-1/PD-L1 pathways, have marked a paradigm

Read More »

Recent Articles